Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Chemotherapy

Is adjuvant chemotherapy an option for stage II colon cancer?

Nature Reviews Clinical Oncology volume 8, pages 574–576 (2011)Cite this article

Subjects

A retrospective study of Medicare patients over 65 years of age with stage II colon cancer, showed that adjuvant chemotherapy did not improve overall survival, even in patients with poor prognostic factors. But, does this mean that these patients should not be offered this treatment option?boxed-text

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gray, R. et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370, 2020–2029 (2007).

    Article  Google Scholar 

  2. Gunderson, L. L., Jessup J. M., Sargent, D. J., Greene, F. L. & Stewart, A. K. Revised TN categorization for colon cancer based on national survival outcomes data. J. Clin. Oncol. 28, 264–271 (2009).

    Article  Google Scholar 

  3. O'Connor, E. S. et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J. Clin. Oncol. 29, 3381–3388 (2011).

    Article  Google Scholar 

  4. Sargent, D. J. et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J. Clin. Oncol. 28, 3219–3226 (2010).

    Article  CAS  Google Scholar 

  5. André, T. et al. Current issues in adjuvant treatment of stage II colon cancer. Ann. Surg. Oncol. 13, 887–898 (2006).

    Article  Google Scholar 

  6. Niedzwiecki, D. et al. Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. J. Clin. Oncol. 29, 3146–3152 (2011).

    Article  Google Scholar 

  7. André, T. et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J. Clin. Oncol. 27, 3109–3116 (2009).

    Article  Google Scholar 

  8. Yothers, G. et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 including survival and subset analyses. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2011.36.4539.

  9. Yothers, G. A. et al. The efficacy of oxaliplatin (Ox) when added to 5-fluorouracil/leucovorin (FU/L) in stage II colon cancer [abstract]. J. Clin. Oncol. 29 (Suppl.), a3507 (2011).

    Article  Google Scholar 

  10. O'Connell, M. J. et al. Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. J. Clin. Oncol. 28, 3937–3944 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology Department, GERCOR, INSERM U938, UPMC, Assistance Publique des Hôpitaux de Paris, Saint-Antoine Hospital, 184 rue du Faubourg Saint-Antoine, Paris, 75012, France

    Christophe Tournigand & Aimery de Gramont

Authors
  1. Christophe Tournigand
    View author publications

    Search author on:PubMed Google Scholar

  2. Aimery de Gramont
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Christophe Tournigand.

Ethics declarations

Competing interests

The authors declare that they have acted as consultants to Sanofi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tournigand, C., de Gramont, A. Is adjuvant chemotherapy an option for stage II colon cancer?. Nat Rev Clin Oncol 8, 574–576 (2011). https://doi.org/10.1038/nrclinonc.2011.139

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrclinonc.2011.139

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer